U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H20ClNO2
Molecular Weight 317.81
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SKF-83959, (R)-

SMILES

CN1CCC2=C(Cl)C(O)=C(O)C=C2[C@H](C1)C3=CC(C)=CC=C3

InChI

InChIKey=JXMYTVOBSFOHAF-OAHLLOKOSA-N
InChI=1S/C18H20ClNO2/c1-11-4-3-5-12(8-11)15-10-20(2)7-6-13-14(15)9-16(21)18(22)17(13)19/h3-5,8-9,15,21-22H,6-7,10H2,1-2H3/t15-/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H20ClNO2
Molecular Weight 317.81
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

(R)-SKF-83959 (MCL 202) is enantiomer of D1 receptor agonist SKF-83959. (R)-SKF-83959 is reported to be a functionally selective dopamine D1 and D5 receptors ligand with much lower affinity to dopamine D2 and D3 receptors. (R)-SKF-83959 like SKF-83959, produced dose related effects on overt behavior (eye blinking) and schedule-controlled performance in squirrel monkeys. (R)-SKF-83959 increases in eye blinking and decreases in rates of fixed-ratio responding. In contrast to the effects of its S-(-) enantiomer, was relatively devoid of behavioral activity up to doses that were approximately 10-fold greater than (R)-SKF-83959. Pretreatment with the selective D1- like receptor antagonist SCH 39166 dose-dependently antagonized increases in eye blinking produced by (R)-SKF-83959, confirming the involvement of D1 mechanisms in its effects.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.49 nM [Ki]
515.0 nM [Ki]
1.53 nM [Ki]
88.6 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Rats were treated with (R)-SKF-83959 (0.0003–1.0 mg/kg) as single i.m. injection
Route of Administration: Intramuscular
In Vitro Use Guide
(R)-SKF-83959 was assayed for affinity at dopamine receptors in rat caudate – putamen tissue from adult male Sprague–Dawley rats. Fresh, rapidly dissected brain tissue was hand-homogenized in 50 mM Tris–HCl buffer pH 7.4, dopamine D1 receptor assays, tissue was incubated with (R)-SKF-83959 or [3H]SCH-23390 (0.30 nM) for 30 min at 30C, using excess cis-flupenthixol (10 mkM) as a blank
Substance Class Chemical
Record UNII
39YLC3L0ZU
Record Status Validated (UNII)
Record Version